GOLDMAN SACHS GROUP INC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q1 2023$51,780
+223.6%
15,365
+32.3%
0.00%
Q3 2022$16,000
-86.9%
11,618
-79.1%
0.00%
Q2 2022$122,000
-87.2%
55,714
-81.4%
0.00%
Q1 2022$954,000
+74.7%
298,877
+129.6%
0.00%
Q4 2021$546,000
-22.8%
130,165
+49.5%
0.00%
Q3 2021$707,000
+3.1%
87,050
-4.2%
0.00%
Q2 2021$686,000
+15.7%
90,892
+33.2%
0.00%
Q1 2021$593,000
-72.4%
68,261
-74.7%
0.00%
-100.0%
Q4 2020$2,150,000
+35.6%
269,762
+35.7%
0.00%
Q3 2020$1,586,000
-14.5%
198,795
+6.1%
0.00%
-100.0%
Q2 2020$1,855,000
+217.1%
187,388
+147.6%
0.00%
Q1 2020$585,000
+265.6%
75,675
+82.4%
0.00%
Q4 2019$160,000
+135.3%
41,499
+207.1%
0.00%
Q3 2019$68,000
-5.6%
13,514
+24.3%
0.00%
Q2 2019$72,000
-31.4%
10,873
-21.9%
0.00%
Q1 2019$105,000
-59.9%
13,925
-57.2%
0.00%
Q4 2018$262,000
-13.5%
32,531
+38.3%
0.00%
Q3 2018$303,000
+154.6%
23,525
+124.5%
0.00%
Q2 2018$119,000
-59.8%
10,481
-75.1%
0.00%
Q1 2018$296,000
+102.7%
42,013
+86.6%
0.00%
Q4 2017$146,000
+14.1%
22,521
-1.8%
0.00%
Q4 2015$128,000
+5.8%
22,941
+19.2%
0.00%
Q3 2015$121,00019,2500.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders